Efficacy and Safety of Daprodustat Compared with Darbepoetin Alfa in Japanese Hemodialysis Patients with Anemia

Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis

(2019) Nan Chen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Update on Anemia in ESRD and Earlier Stages of CKD: Core Curriculum 2018

(2018) Steven Fishbane et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Effects of Daprodustat, a Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Anemia Management in Japanese Hemodialysis Subjects

(2016) Tadao Akizawa et al.   AMERICAN JOURNAL OF NEPHROLOGY

The iron cycle in chronic kidney disease (CKD): from genetics and experimental models to CKD patients

(2013) K. Zumbrennen-Bullough et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Mechanisms of Anemia in CKD

(2012) J. L. Babitt et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Notice

(2012)   Kidney International Supplements

Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes

(2010) Scott D. Solomon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Intestinal Hypoxia-Inducible Transcription Factors Are Essential for Iron Absorption following Iron Deficiency

(2009) Yatrik M. Shah et al.   Cell Metabolism

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

(2009) Marc A. Pfeffer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes

(2008) Lynda A. Szczech et al.   KIDNEY INTERNATIONAL